Mode
Text Size
Log in / Sign up

CPAP therapy shows no significant reduction in cancer incidence among obstructive sleep apnea patientsDoes treating sleep apnea with CPAP lower your cancer risk? The answer isn't clear

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: CPAP shows no significant effect on cancer incidence in OSA patients based on current RCT data.

A meta-analysis pooled data from three randomized controlled trials (SAVE, RICCADSA, ISAACC) involving patients with obstructive sleep apnea. The analysis compared cancer incidence between those receiving continuous positive airway pressure therapy and control groups, using adverse event data from trials not primarily designed to assess cancer outcomes.

The primary finding was no statistically significant difference in cancer incidence between CPAP and control groups, with a confidence interval of 0.55 to 1.68 that crosses 1.0. The effect size, absolute numbers, and p-value were not reported. Safety and tolerability data specific to this analysis were not reported.

Key limitations include that the trials were not designed with cancer as a primary outcome, and the confidence interval is wide, indicating substantial uncertainty. The analysis does not provide evidence that CPAP therapy reduces cancer risk in OSA patients. Clinicians should continue to focus on established benefits of CPAP for sleep apnea management rather than cancer prevention.

Many people with obstructive sleep apnea use a CPAP machine every night, hoping it does more than just help them breathe. Some have wondered if treating this serious sleep disorder might also lower the risk of developing cancer. A fresh look at the data from three large clinical trials aimed to find out.

The analysis combined results from thousands of patients with sleep apnea who were randomly assigned to use CPAP or not. When researchers tracked who developed cancer, they found no statistically significant difference between the two groups. The numbers showed a wide range of possibilities—from a potential reduction in risk to a potential increase—but the most honest takeaway is that the effect, if there is one, remains unclear.

It's important to understand what this result means. These trials weren't originally designed to study cancer; they were looking at heart and stroke risks. The cancer data came from tracking side effects, which isn't the most precise way to measure this outcome. The confidence interval, a statistical measure of certainty, crossed the line of 'no difference.' So, for now, we can't say CPAP prevents cancer. The best reason to use your CPAP is still the proven one: to treat your sleep apnea and protect your heart.

What this means for you:
CPAP treats sleep apnea, but current evidence doesn't show it prevents cancer.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Obstructive sleep apnea (OSA) has been hypothesised to promote cancer via intermittent hypoxia, and assessing what happens when OSA is controlled by continuous positive airway pressure (CPAP) may provide valuable insight. We conducted a meta-analysis of three randomised controlled trials (SAVE, RICCADSA, ISAACC) assessing cancer incidence from adverse event data on neoplasms among OSA patients randomised to continuous positive airway pressure (CPAP) versus control. Across trials, cancer incidence was similar between groups, and meta-analysis showed no statistically significant difference (CI 0.55-1.68). Treating sleep apnea with CPAP does not appear to markedly reduce the risk of incident cancers.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.